Beta Drugs Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 157.87 | 124.85 | 79.46 | 65.32 | 58.05 |
| Expenses | |||||
| Material consumed | 85.62 | 72.50 | 44.38 | 35.33 | 31.76 |
| Manufacturing expenses | 13.04 | 10.35 | 8.48 | 7.29 | 6.06 |
| Personnel expenses | 13.42 | 8.72 | 6.06 | 4.93 | 3.42 |
| Selling expenses | 0.03 | 0.06 | - | 0.05 | 0.09 |
| Adminstrative expenses | 14.57 | 8.03 | 5.23 | 5.97 | 6.42 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 126.68 | 99.66 | 64.15 | 53.57 | 47.74 |
| Operating profit | 31.20 | 25.18 | 15.31 | 11.75 | 10.31 |
| Other recurring income | 1.04 | 0.86 | 0.61 | 0.42 | 0.32 |
| Adjusted PBDIT | 32.24 | 26.04 | 15.92 | 12.17 | 10.62 |
| Financial expenses | 0.84 | 0.41 | 0.77 | 0.64 | 0.73 |
| Depreciation | 6.19 | 5.47 | 5.27 | 2.58 | 2.42 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 25.21 | 20.16 | 9.88 | 8.95 | 7.47 |
| Tax charges | 6.39 | 5.92 | 2.90 | 1.85 | -0.25 |
| Adjusted PAT | 18.82 | 14.25 | 6.98 | 7.10 | 7.71 |
| Non recurring items | - | - | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 18.82 | 14.25 | 6.98 | 7.10 | 7.71 |
| Earnigs before appropriation | 62.72 | 44.11 | 29.86 | 22.89 | 15.79 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 62.72 | 44.11 | 29.86 | 22.89 | 15.79 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis